Treatment of the LNCaP prostate cancer cell line with curcumin increased the sensitivity of cells to TRAIL-induced apoptosis and induced the externalization of phosphatidylserine, a marker for early apoptosis [132]. This evidence concerns the gene TNFSF10 and prostate carcinoma.